Year: 2025
Type: article
Abstract: D In the world of holobionts the concept of identity has changed: the host organism and its microbiota should be seen as a single genomic, metabolic and functional unit; in this perspective, the microbiota can modulate the bioavailability and efficacy of non-antibiotic drugs, undergoing, vice versa, alterations in terms of bacterial composition. The aim of this review is to explore the intricate relationship between drugs used for the management of type 2 diabetes and the gut microbiota, and how this interaction could contribute to pharmacological efficacy.
Source: il Diabete
DOI: 10.30682/ildia2501c
Institution: Magna Graecia University
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W4409903576